ARTICLE | Clinical News
Medarex regulatory update
August 21, 1995 7:00 AM UTC
MEDX (Annandale, N.J.) received European Patent No. 255,249 covering MEDX's bispecific antibody technology and the use of bispecific antibodies for therapeutic purposes. The technology combines two mo...